American Oncology Network Expands Arkansas Presence, Adds Conway Hematology Oncology to National Network

/in /by

CONWAY, Ark., Aug. 5, 2025– Conway Hematology Oncology (CHO), a trusted provider of hematology and oncology care in Conway, Arkansas, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices.

This partnership enables CHO to expand patient-focused services, grow clinical trial offerings, and pursue new market opportunities—while continuing to provide the high-quality, compassionate care that has defined the practice for more than 25 years.

Dr. Sue Tsuda, a Board-certified medical oncologist and hematologist, co-founded Conway Hematology Oncology in 1998 and has cared for patients in the Conway area ever since. She earned her medical degree from Northwestern University and completed her residency at Evanston Hospital. Dr. Tsuda completed fellowships in hematology at Rush-Presbyterian-St. Luke’s Medical Center, blood banking at Barnes Hospital, and medical oncology at Washington University in St. Louis. She has conducted research at Washington University and previously served as an assistant professor at the University of Arkansas for Medical Sciences. Dr. Tsuda is a member of the American Society of Clinical Oncology and the Southern Association of Oncology and has been recognized on The Best Doctors in America list annually since 1996.

Christine Lightfoot, a Board-certified nurse practitioner, earned both her Bachelor and Master of Science in nursing with a concentration in family nurse practice from the University of Central Arkansas in Conway. She has been caring for patients in Arkansas since 2010.

Courtney Nash,  a Board-certified nurse practitioner, earned her Master of Science in nursing from the University of Central Arkansas in Conway and her Bachelor of Science in nursing from the University of Arkansas in Fayetteville. She has been providing care in Arkansas since 2006.

“We’re proud to join American Oncology Network,” said Dr. Tsuda. “AON’s commitment to personalized, high-quality care delivered in a community setting mirrors the mission we’ve upheld for decades. This partnership enables us to broaden our services and bring advanced treatments to our patients, while continuing to provide the compassionate care they’ve come to expect.”

Conway Hematology Oncology offers comprehensive community-based oncology services to patients in Conway and surrounding areas, including the latest diagnostic and treatment technologies, private exam rooms, an onsite laboratory, and infusion suites designed for comfort and privacy.

“We are thrilled to welcome Conway Hematology Oncology to the American Oncology Network,” said  Todd Schonherz, AON’s chief executive officer. “CHO is well known for its outstanding patient-centered care, and their clinical expertise is a perfect fit with AON’s mission to make high-quality, individualized cancer treatment accessible in local communities.”

“On behalf of AON, I’m excited to welcome the CHO team to our network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their dedication to delivering excellent care in a community setting has made a lasting difference in Conway. Their experience and values will strengthen our collective efforts to improve community cancer care across the country.”

Dr. Tsuda, Christine Lightfoot, and Courtney Nash are now accepting new patients. For more information about AON, visit AONcology.com. To learn more about Conway Hematology Oncology, visit conwayhematologyoncology.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Conway Hematology Oncology
Conway Hematology Oncology (CHO) has been a trusted name in Conway, Arkansas cancer care since 1998. In August 2025, the practice joined American Oncology Network (AON). Conway Hematology Oncology is the longest running full-time cancer clinic in Faulkner County, Arkansas. The practice understands the profound effects cancer can have on a person and is dedicated to the physical and mental health of cancer patients and their families, working hard to provide patients with the best cancer treatment in an atmosphere of caring encouragement. Conway offices are equipped with the latest diagnostic and treatment technologies including an onsite laboratory, CT scanning and chemotherapy administration. Learn more at conwayhematologyoncology.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists

/in /by

FORT MYERS, Fla., July 23, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, has received reaccreditation from

the Accreditation Committee of the College of American Pathologists (CAP) for its Central Laboratory in Fort Myers, Florida. The recognition follows a recent on-site inspection conducted as part of the CAP’s Accreditation Programs.

Recognized for its rigorous standards and commitment to quality, CAP accreditation helps ensure laboratories operate at the highest levels of accuracy and reliability—contributing to improved patient outcomes and reduced clinical risk.

“We are pleased to receive reaccreditation from the College of American Pathologists (CAP) for our central laboratory in Fort Myers,” said Dr. Ryan Olson, medical director of pathology. “The AON central laboratory serves community oncology practices across the country, aiding thousands of patients in receiving timely and accurate results to support better treatment decisions. This reaccreditation reflects our team’s dedication to upholding the highest quality standards.”

Dr. Ryan Olsen, American Oncology Network

“Laboratory medicine plays a critical role in modern cancer care,” said Todd Schonherz, chief executive officer of AON. “CAP reaccreditation reflects the high standards we set for patient care across the entire network. I’m proud of our central lab team for maintaining this elite level of quality and helping ensure our community oncology practices have the tools they need to deliver precise, timely care.”

As part of the accreditation process, CAP inspectors review a laboratory’s records, quality control procedures, staff qualifications, equipment facilities, safety practices and overall management. The program is designed to ensure that laboratories meet or exceed the industry’s most current standards and best practices.

 In addition to accreditation, the College of American Pathologists supports more than 23,000 laboratories through proficiency testing, quality improvement tools, and best-in-class protocols and guidelines. Built on a foundation of pathologist expertise, the CAP partners with laboratories around the world to drive operational excellence, improve diagnostic confidence and ensure high-quality patient care.

###

About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

More Than 40 American Oncology Network Clinics Across 18 States and Washington, D.C., Now Offering Bispecific T-cell Engager Therapies to Patients

/in /by

AON community oncology practices across the nation offering groundbreaking immunotherapy to expand treatment options for hard-to-treat cancers

FORT MYERS, Fla., July 21, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is now offering Bispecific T-cell Engager (BiTE) therapy—also known as BiTE therapy—at more than 40 partner practice clinics in 18 states and Washington, D.C. This advancement brings cutting-edge cancer treatment directly to patients in community settings, expanding access to a promising class of immunotherapies that may offer new hope for those with cancers resistant to standard treatments.

Bispecific therapies represent a major breakthrough in cancer care. These innovative therapies engage a patient’s own immune system by targeting two different molecules—one on a cancer cell and one on a T cell (a type of immune cell). By binding to both simultaneously, bispecific antibodies act as a bridge, directing the T cell to the tumor and triggering the immune system to attack the cancer directly.

“At AON, we’re committed to staying at the forefront of cancer care by integrating innovative therapies like bispecific antibodies into our clinical offerings,” said Melody Chang, RPh, MBA, BCOP, vice president of pharmacy operations at AON. “These therapies are an important part of our personalized treatment approach and have already shown promise in improving outcomes for patients with some of the most challenging cancers.”

Since March 2025, AON has provided bispecific antibody therapy to patients with acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma and extensive-stage small cell lung cancer.

“Bispecific therapies are particularly important for patients whose cancers no longer respond to traditional treatments,” said Dr. Stephen “Fred” Divers, chief medical officer at AON. “By expanding access to these therapies in the community setting, AON is helping patients stay close to home while receiving some of the most advanced treatment options available.”

AON’s implementation of BiTE therapies ensures patients across its national network can benefit from these innovations without the need to travel to academic medical centers or major research institutions.

How Bispecific Therapies Work:

  • Dual Targeting: Bispecific antibodies are engineered to recognize two targets—typically a cancer cell marker and a T cell receptor.
  • T Cell Engagement: The therapy draws T cells to the cancer site, increasing immune activity at the tumor.
  • Targeted Immune Activation: This precise approach enhances the immune response, improving the likelihood of destroying cancer cells while minimizing harm to healthy tissue.

In addition to offering these therapies, AON actively participates in clinical trials and collaborates with leading researchers to explore new applications of bispecific antibodies in oncology.

“AON’s expansion of bispecific antibody therapies reflects our mission to bring the most advanced treatments to local communities,” said Todd Schonherz, chief executive officer at AON. “Our focus on innovation and access allows patients to receive world-class care from trusted local providers without having to leave their support systems behind.”

To learn more about how bispecific therapies work, visit: https://www.aoncology.com/education-posts/understanding-bispecific-therapies-bite/

AON partner practices offering bispecific therapies include:

(**Practices Offering Complete Outpatient Services)

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Florida Oncology and Hematology Expands Fort Myers Clinic, Adds PET Services

/in /by

Local oncology practice enhances state-of-the-art location to include radiology services that improve cancer care for the Lee County community.

FORT MYERS, FL, July 15, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has expanded its Fort Myers clinic at 14551 Hope Center Loop to include radiology services. Current and prospective patients can call (239) 264-7026 for more information or to schedule an appointment.

Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now seeing patients at the new location.

The expanded clinic offers PET services, 12 exam rooms for patient consultations, nearly 30 infusion chairs and an on-site lab.

“Our Fort Myers practice now includes radiology services, allowing us to better meet the needs of our patients throughout Lee County,” said medical director, Dr. Van den Bergh. “Delivering compassionate, high-quality care remains our top priority. This expansion enables us to provide that care in a more comprehensive and comfortable setting. We’re grateful for the trust our patients place in us and look forward to welcoming them to the expanded space.”

Florida Oncology and Hematology operates five clinics serving patients in Cape Coral, Clearwater, Fort Myers, Naples and surrounding areas. The practice is dedicated to providing personalized care plans tailored to each patient’s unique needs. As a community-based oncology group, it offers high-quality, affordable care in a supportive and accessible environment.

The practice is a partner of American Oncology Network, one of the fastest-growing community oncology networks in the United States. Through this partnership, patients have access to expanded services such as an in-house specialty pharmacy, which provides home delivery of select medications, along with other supportive care resources.

“We’re proud to continue growing alongside our community,” said Dr. Parsa. “The addition of PET services not only allows us to provide diagnostic PET and CT imaging, but it also provides the technology to offer innovative Radioligand Therapy to treat a variety of cancers such as prostate and neuroendocrine tumors in a more direct and targeted way. Now, we’re able to deliver additional services for our patients—all in one convenient location.”

For more information about AON, visit AONcology.com. To learn more about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Auerbach Hematology and Oncology Joins American Oncology Network, Becomes The Center for Cancer and Blood Disorders – Baltimore

/in /by

BALTIMORE, Md., July 15, 2025 – Auerbach Hematology and Oncology Associates PC, a trusted name in hematology and oncology care in Baltimore, Maryland, is proud to announce it has joined American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices. The practice, located at 5233 King Ave., Suite 308, will now be known as The Center for Cancer and Blood Disorders (CCBD)—Baltimore.

This partnership enables Michael Auerbach, MD, FACP,  Huzefa Bahrain, DO, FACP and Stephanie Horrocks, CRNP to expand their patient-focused services, grow clinical trial offerings, and pursue new market opportunities—while continuing to provide the high-quality, compassionate care that has defined their practice for 24 years.

Dr. Auerbach is a Board-certified hematologist and oncologist who earned his medical degree from New York Medical College in Valhalla, New York. He completed his internship and residency in internal medicine at the Cleveland Clinic Foundation in Ohio. He then completed fellowship training in hematology and oncology at Columbia University School of Medicine in New York. An internationally renowned expert on the treatment of iron deficiency anemia, he is the author of Treatment of Iron Deficiency and Iron Deficiency Anemia in adults, Anemia in Pregnancy and Identifying the Cause of Iron Deficiency for UpToDate.  He is currently a Clinical Professor of Medicine at Georgetown University School of Medicine and is on the American Society of Hematology Guidelines Committee for the Diagnosis and Treatment of Iron Deficiency and Iron Deficiency Anemia.

Dr. Bahrain is a Board-certified hematologist and oncologist who earned his medical degree from Nova Southeastern University in Miami. He completed his internship and residency in internal medicine at MFSMC, University of Maryland where he served as chief resident. He went on to complete his hematology-oncology fellowship at the Washington Cancer Institute, Georgetown University, where he was named chief fellow. Dr. Bahrain is a nationally known key opinion leader for the use of intravenous iron for the treatment of iron deficiency with multiple high quality publications in the field.

Stephanie Horrocks is a certified registered nurse practitioner who earned her Master of Science in nursing from Maryville University in St. Louis. She has worked alongside Dr. Auerbach and Dr. Bahrain since 2020, specializing in the management of complex hematologic conditions. With nearly a decade of experience as a nurse practitioner in the Baltimore area, she is known for her strong clinical judgment, attention to detail and unwavering dedication to patient advocacy. She plays an integral role in care coordination and treatment planning, working closely with multidisciplinary teams to improve outcomes and enhance the patient experience.

“We are excited to partner with American Oncology Network and establish The Center for Cancer and Blood Disorders – Baltimore clinic,” said Dr. Auerbach. “Both CCBD and AON are dedicated to providing innovative, high-quality, and personalized cancer care in a community setting—just as Dr. Bahrain, Stephanie, and I have always done. This collaboration enhances our ability to deliver advanced treatments while preserving the patient-centered approach our patients rely on. We look forward to offering expanded services through this partnership to make care more convenient and improve outcomes for those we serve.” 

CCBD provides community-based oncology services to patients in Baltimore, Bethesda, and Germantown, Maryland. The practice offers comprehensive cancer care, including diagnostics, treatment, clinical trials, survivorship programs and patient support – all delivered close to home to reduce travel burdens for patients and their families. CCBD clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

“We are pleased to welcome Dr. Auerbach, Dr. Bahrain, and Stephanie to the American Oncology Network and CCBD,” said  Todd Schonherz, AON’s chief executive officer. “They are known for the exceptional, patient-centered care they provide, and their expertise aligns perfectly with AON’s mission to deliver personalized cancer care tailored to each patient’s unique needs. We’re eager to collaborate and learn from the knowledge and experience they bring.”

“On behalf of AON, I am delighted to welcome Dr. Auerbach, Dr. Bahrain, and Stephanie to the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Their dedication to providing quality care in a community setting has had a significant impact in Baltimore. Their expertise and commitment will greatly enhance our services and strengthen the care we provide across the network.”

“We’re thrilled to welcome Dr. Auerbach, Dr. Bahrain, and Stephanie to the CCBD family,” said Ralph Boccia, MD, FACP, a longtime CCBD physician. “Their reputation for delivering high-quality, compassionate care speaks for itself, and we’re excited to benefit from their expertise. With their addition, we’re now expanding our reach to serve patients in Baltimore, and we look forward to growing together to meet the needs of even more communities across Maryland.”

Dr. Auerbach, Dr. Bahrain and Stephanie are now accepting new patients. For more information about AON, visit AONcology.com. To learn more about The Center for Cancer and Blood Disorders – Baltimore, visit ccbdmd.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About The Center for Cancer and Blood Disorders – Baltimore
Michael Auerbach, MD, FACP and Huzefa Bahrain, DO, FACP have been serving cancer patients at Auerbach Hematology and Oncology Associates PC, a trusted name in Baltimore, Maryland cancer care, for 24 years. In July 2025, Auerbach Hematology and Oncology Associates PC, joined American Oncology Network (AON). The practice is now known as The Center for Cancer and Blood Disorders (CCBD)—Baltimore.

Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda and Germantown, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Hope Cancer Care of Nevada and American Oncology Network Open New Henderson Clinic

/in /by

Nevada-based community oncology practice opens its third Nevada location, expanding oncology care access for Clark County area patients

HENDERSON, Nev, July 8, 2025 — Community oncology practice Hope Cancer Care of Nevada, a partner practice of American Oncology Network (AON), is pleased to announce that patients now have an additional choice for oncology and hematology services in Clark County due to its continued expansion in Nevada with a new location opening in Henderson. The addition of this clinic – located at 3035 W. Horizon Ridge Parkway, Suite 100 – offers Henderson-area patients another opportunity to choose a community oncology practice that best suits their unique needs.

Board-certified medical oncologist Dr. Raja S. Mehdi is now accepting patients at the new Hope Cancer Care of Nevada – Henderson location. The new clinic includes private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, and a specialty pharmacy for oral oncolytics. New and existing patients can call (702) 508-9128 for more information or to schedule an appointment.

“We’re excited to welcome patients to our new Henderson location, where we will provide the same high-quality care that we do in all of our clinics,” said Dr. Mehdi. “We have a patient-first mindset, and we hold ourselves to a high-standard of continuously providing exceptional, compassionate care, which is the standard in all of Hope Cancer Care of Nevada’s clinic locations. We look forward to serving our patients at our new clinic in Henderson.”

The Hope Cancer Care of Nevada team now includes three Nevada locations. The practice is committed to providing the community with innovative care for cancer and blood disorders that is delivered holistically based on research and evidence-based medicine. Hope Cancer Care of Nevada patients have access to a diverse range of services for diagnosis, treatment, survivorship, and patient support that are close to home, eliminating the need to travel long distances to receive care.

“We are looking forward to welcoming our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Medhi. “This new location will allow us to make access to care more convenient for Clark County patients who reside in Henderson, and we look forward to providing them the exceptional, high-quality one-on-one personalized care they have come to expect from Hope Cancer Care of Nevada.”

For more information about AON, visit AONcology.com. To learn more about Hope Cancer Care of Nevada, visit hccnevada.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Hope Cancer Care of NevadaSpecialists in the diagnosis and treatment of cancer and blood disorders, Hope Cancer Care of Nevada providers have been serving patients in the Las Vegas and Pahrump, Nevada areas for 15 years. As a community-based practice, Hope Cancer Care of Nevada offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at hccnevada.com/.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Florida Oncology and Hematology Relocates Naples Health Parkway Clinic to Larger Location in Lintree Medical Plaza; Adds PET Services

/in /by

Local oncology practice moves to expanded location to enhance cancer care for Collier County community.

NAPLES, FL, July 1, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Health Parkway clinic in Naples to a larger suite at 15455 Collier Blvd., Suite 101, in the Lintree Medical Plaza. Current and prospective patients can call (239) 231-7258 for more information or to schedule an appointment.

Board-certified medical oncologist Ferdy Santiago, MD and Board-certified hematologist Deborah Glick, MD, are now seeing patients at the new location.

The expanded clinic offers PET services, an infusion room, additional private exam rooms for patient-physician discussions, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

“Our Health Parkway practice has moved to a larger suite in the Lintree Medical Plaza to better accommodate the needs of our Collier County patients,” said Dr. Santiago. “Providing exceptional, compassionate care remains our top priority, and this relocation allows us to do that in an even more comfortable and comprehensive setting. We’re grateful for our patients’ ongoing trust and look forward to welcoming them to the new space.”

Florida Oncology and Hematology’s other Naples-area clinic, located at 708 Goodlette-Frank Road, Suite 302 also recently expanded into a larger suite in June.

Florida Oncology and Hematology has five clinic locations serving patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas. The practice is committed to delivering personalized care plans tailored to each patient’s individual needs. As a community-based practice, it offers affordable, high-quality treatment in a supportive, accessible environment.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, American Oncology Network makes additional patient care and services available such as access to the in-house specialty pharmacy, which provides home delivery of select medications and other supportive care resources.

“We’re excited to continue growing with our community,” said Dr. Santiago. “This new space allows us to expand services and bring in additional staff, ensuring each patient receives the individualized attention they deserve.”

For more information about AON, visit AONcology.com. To learn more about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Florida Oncology and Hematology Moves Naples-Goodlette Clinic to Larger Location

/in /by

Local oncology practice moves to a new, expanded location to continue providing enhanced cancer care to the Naples-Goodlette community.

NAPLES, FL, June 11, 2025 – Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Goodlette clinic in Naples to 708 Goodlette-Frank Road, Suite 302, 3rd Floor. Current or prospective patients can call (239) 231-7260 for inquiries or to schedule an appointment.

Board-certified medical oncologists Zanetta Lamar, MD,  Ferdy Santiago, MD, and Board-certified hematologist Deborah Glick, MD are now accepting patients at the new, larger Naples-Goodlette location.

The new clinic includes additional private exam rooms that provide dedicated space for patient-physician conversations, an infusion room, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics.

“Our Goodlette practice has moved to a larger suite to better serve our Naples area patients,” said Dr. Santiago. “We hold ourselves to a high standard of continuously providing exceptional, compassionate care that is central to our patient-first mindset, and is the standard in all of Florida Oncology and Hematology’s five clinic locations. We appreciate our patients’ continued trust and look forward to serving them at our newly expanded Goodlette address in Naples.”

Florida Oncology and Hematology provides care to patients living in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas. The practice ensures patients receive personalized care and treatment plans that are designed exclusively for their unique needs. As a community-based practice, Florida Oncology and Hematology provides affordable care in a comfortable environment while offering high-quality, state-of-the-art treatment in convenient locations.

The practice is a partner of American Oncology Network, one of the nation’s fastest-growing community-based oncology networks. Through this partnership, American Oncology Network makes additional patient care and services available such as access to the in-house specialty pharmacy with home delivery of certain medications among other benefits.

“We are excited to welcome our patients to the new space, where we will continue to prioritize their health and well-being,” said Dr. Santiago. “The relocation will allow us to expand patient services and therapeutics, while also providing a larger space for additional staff to deliver one-on-one care.”

For more information about AON, visit AONcology.com. For more information about Florida Oncology and Hematology, visit floridaonc.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Florida Oncology and Hematology
Specialists in the diagnosis and treatment of cancer and blood disorders, Florida Oncology and Hematology serves patients in Cape Coral, Clearwater, Fort Myers, and Naples, Florida. As a community-based practice, it offers a full range of exceptional cancer services, providing the highest quality treatment based on research and focused on the whole person. Learn more at floridaonc.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting

/in /by

Several AON physicians and leaders shared new cancer research at one of oncology’s most influential gatherings

FORT MYERS, Fla., June 3, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing networks of community oncology practices, is pleased to announce that multiple research studies co-authored by AON physicians and leaders were selected for presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, held May 30-June 3 in Chicago.

The following abstracts were accepted after a rigorous review process and presented through poster discussions, oral presentations or online publication:

“It’s an honor to share our research and latest findings with peers at ASCO,” said Dr. Boccia, who is also the chairperson of AON’s Research Committee. “This platform fosters collaboration, innovation, and the advancement of clinical oncology. Our participation reflects our ongoing commitment to improving cancer care through evidence-based practices.”

“Oncology research isn’t just about discovering new treatments—it’s about deepening our understanding of cancer itself,” said Dr. Stephen “Fred” Divers, AON’s chief medical officer. “Each study brings us closer to more precise care, better outcomes and, ultimately, a cure. We’re proud to contribute to this vital mission.”

“Having so many of our physicians and leaders featured at ASCO speaks volumes about the caliber of talent across our network,” said Todd Schonherz, AON’s chief executive officer. “We are proud to support their work, which not only advances the field of oncology but also reinforces AON’s culture of innovation and learning.”

ASCO is one of the leading professional organizations for oncology professionals, offering more than 145 hours of education, collaboration and research insights each year during its annual meeting.

AON has numerous practices actively participating in clinical research. Currently, AON practices offer access to more than 150 clinical trials, making cutting-edge treatment options available within local communities.

For more information about AON, visit www.AONcology.com.

###

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network

/in /by

Six AON community oncology practice partners now offering radioligand therapeutics for prostate and neuroendocrine cancers

Fort Myers, Fla., May 21, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it is expanding access to cutting-edge radioligand therapies (RLT), providing more patients with targeted treatment options for certain metastatic and rare cancers. To date, more than 300 treatments have been delivered to nearly 70 patients across six AON partner practices, demonstrating both the growing demand for and success of these advanced therapies.

Radioligand therapies are now offered at the following AON practices:

These practices offer three FDA-approved radiopharmaceuticals:

  • Pluvicto™ – for treatment of metastatic castration-resistant prostate cancer (mCRPC)
  • Lutathera® – for adults with gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
  • Xofigo® (radium-223 dichloride) – for symptomatic mCRPC with bone metastases

“Radioligand therapy allows us to deliver highly targeted radiation directly to cancer cells, minimizing damage to healthy tissue and improving patient outcomes,” said Guy Messer, AON vice president of radiation and radiology services. “Our expansion of these therapies reflects AON’s continued commitment to ensuring that patients in community settings can access leading-edge treatments without having to travel far from home.”

Radioligand therapy, also know as radiopharmaceutical therapy, involves attaching a radioactive isotope to a targeting molecule that is injected into the bloodstream. This molecule binds to specific receptors on tumor cells, delivering a precise dose of radiation that damages or kills cancerous cells while sparing surrounding tissue.

Pluvicto™ is the first targeted radioligand therapy approved by the FDA to treat prostate-specific membrane antigen (PSMA)-positive mCRPC. Xofigo® is approved for men with mCRPC that has spread to the bone and who have already received androgen deprivation therapy. Lutathera® remains the only approved radiopharmaceutical for treating adult patients with GEP-NETs—a rare but increasingly diagnosed type of cancer that can develop in the pancreas, stomach, intestines or appendix.

“Continuing to increase the availability of these advanced radiopharmaceutical therapies in community oncology practices across the nation is a major step forward in personalized cancer care,” said Dr. Stephen “Fred” Divers, AON chief medical officer. “It’s part of AON’s broader mission to ensure patients nationwide have access to the latest innovations in oncology, without sacrificing the personalized care they receive close to home.”

AON expects continued growth in radioligand therapy utilization as additional sites gain the infrastructure and regulatory clearances needed to administer these specialized treatments.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 290 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com